Congenital Orbital Rhabdomyosarcoma

被引:2
作者
Eghtedari, Masoomeh [1 ]
Farsiani, Amir Reza [1 ]
Bordbar, Mohammad Reza [2 ]
机构
[1] Shiraz Univ Med Sci, Poostchi Ophthalmol Res Ctr, Dept Ophthalmol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Hematol Res Ctr, Sch Med, Shiraz, Iran
关键词
Rhabdomyosarcoma; Orbit; Congenital tumor; Exenteration;
D O I
10.1159/000481533
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Rhabdomyosarcoma (RMS) is the most common malignant tumor of the orbit in children, but it is rarely present at birth. We report a large congenital orbital RMS with intracranial extension in a newborn baby. A newborn baby girl was referred to our hospital due to severe right-eye exophthalmia. Imaging studies showed an orbital mass with intracranial extension. Treatment was started with a course of neoadjuvant chemotherapy followed by right orbital exenteration and intracranial resection of the tumor. Histologic examination of the mass showed undifferentiated malignant small-cell tumor. Immunohistochemical study proved it to be RMS. The patient was categorized as intermediate-risk RMS and chemotherapy was continued accordingly with VAC regimen. In spite of treatment, the infant developed intracranial recurrence at the age of 6 months and died 1 month later. Congenital orbital RMS has a poor prognosis. Reconstruction surgery should be deferred due to high rate of recurrence and low chance of survival. A multidisciplinary approach might increase the survival of these patients. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:165 / 169
页数:5
相关论文
共 8 条
  • [1] Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
    Arndt, Carola A. S.
    Stoner, Julie A.
    Hawkins, Douglas S.
    Rodeberg, David A.
    Hayes-Jordan, Andrea A.
    Paidas, Charles N.
    Parham, David M.
    Teot, Lisa A.
    Wharam, Moody D.
    Breneman, John C.
    Donaldson, Sarah S.
    Anderson, James R.
    Meyer, William H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5182 - 5188
  • [2] Chen B, 2007, CLIN OPHTHALMIC ONCO, P581
  • [3] Huh WW, 2011, MD ANDERSON SOLID TU, P61, DOI 10.1007/978-1-4419-0374-7_4
  • [4] DEVELOPMENTAL ORIGINS OF FUSION-NEGATIVE RHABDOMYOSARCOMAS
    Kikuchi, Ken
    Rubin, Brian P.
    Keller, Charles
    [J]. CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY: MYOGENESIS, 2011, 96 : 33 - 56
  • [5] Treatment of orbital rhabdomyosarcoma: Survival and late effects of treatment - Results of an international workshop
    Oberlin, O
    Rey, A
    Anderson, J
    Carli, M
    Raney, RB
    Treuner, J
    Stevens, MCG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 197 - 204
  • [6] A Clinical Update and Radiologic Review of Pediatric Orbital and Ocular Tumors
    Rao, Ajay A.
    Naheedy, John H.
    Chen, James Y. -Y.
    Robbins, Shira L.
    Ramkumar, Hema L.
    [J]. JOURNAL OF ONCOLOGY, 2013, 2013
  • [7] PROGNOSTIC FACTORS IN 951 NONMETASTATIC RHABDOMYOSARCOMA IN CHILDREN - A REPORT FROM THE INTERNATIONAL RHABDOMYOSARCOMA WORKSHOP
    RODARY, C
    GEHAN, EA
    FLAMANT, F
    TREUNER, J
    CARLI, M
    AUQUIER, A
    MAURER, H
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (02): : 89 - 95
  • [8] Orbital Cyst: Prenatal Diagnosis
    Singh, Arun D.
    Traboulsi, Elias I.
    Reid, Janet
    Patno, Donna
    Chapa, Jeffrey
    Rodriguez, Ricardo
    Iben, Sabine
    Schoenfield, Lynn
    [J]. OPHTHALMOLOGY, 2009, 116 (10) : 2042 - 2043